Aidigong says 2024-25 annual results still pending amid missing Shenzhen Aidigong financial data

• Aidigong Maternal & Child Health reported it cannot set a timetable for releasing its 2024 and 2025 annual results.
• Delay stems from difficulties obtaining documents and financial information for key subsidiary Shenzhen Aidigong.
• Trading in the company’s Hong Kong-listed shares has been suspended since Feb. 21, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aidigong Maternal & Child Health Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260820-12293136), on August 20, 2026, and is solely responsible for the information contained therein.